Our Technology

Portable retinal imager examines retinal microvasculature

We are developing a low-cost, easy-to-use, portable retinal imager designed to non-invasively capture physiological information from the retinal microvasculature, providing a quantitative means of monitoring the progression of various metrics indicative of ophthalmic and systemic disease. Our approach eliminates the need for pupil dilation or contrast dyes and allows for important eye exams to be performed in primary care and community care environments. By positioning our devices in primary care centers, healthcare facilities, pharmacies, and community clinics worldwide, we hope to increase access to high-quality, essential care for millions of at-risk and underserved individuals while reducing the cost of care associated with eye exams.

Vasculature

Initial Focus

Millions of people in the world suffer from diabetes.

Nearly 29 million Americans (9% of the population) have diabetes, with an additional 7 million undiagnosed and 79 million at risk. Globally, more than 371 million people currently suffer from diabetes, a population that is expected to grow to well over 550 million by 2030.

World Diabetes Statistics

Approximately 1 in 3 diabetics currently suffer from diabetic retinopathy

DR is a medical condition that results from prolonged mismanagement of diabetes which manifests as damage to the small blood vessels (or micro-vasculature) of the retina, and is the most frequent cause of blindness among adults. Each year, nearly 65,000 Americans progress to the late stages of the condition and as many as 25,000 lose their eyesight. Through early detection, however, healthcare providers can better manage a patient’s diabetes, preventing the vascular damage that occurs as DR progresses.

  • Diabetics receiving recommended annual eye exam 50%
  • Diabetics who have never had an eye exam 36%
The primary reasons cited for the failure to obtain an annual eye exam are:

  • inconvenience
  • cost
  • lack of symptoms

Prevention of vision loss associated with diabetes is an area of significant need that may benefit from the use of our technology.

Recent News

Stay connected as we continue to grow!

Four Baltimore-area companies share $800K in loans from Anne Arundel casino fund

Four Baltimore-area technology startups have received a total of $800,000 in loans from Anne Arundel County. The county’s VOLT Fund, managed by the Anne Arundel Economic Development Corp., supports entrepreneurs and pre-revenue startups to help them reach key milestones, attract additional funding and grow locally. The fund receives $1.8 million a year from the state’s Small, Minority and Women-Owned Business Investment Fund, which is funded through video lottery revenue from Maryland casinos.  For full story click... read more

Four Emerging Technology Companies Receive VOLT Fund Loans

Annapolis, Maryland – (February 29, 2016) – Today the Anne Arundel Economic Development Corporation (AAEDC) announced that four early stage technology companies in central Maryland have been approved for a total of $800,000 in loans through its VOLT Fund. Awardees include two Anne Arundel County companies, Appian Medical, Inc., and Vixiar Medical Inc., Baltimore City based Vasoptic Medical Inc., and Grip Boost, LLC, a member company at bwtech@UMBC incubator. For full story click... read more

Vasoptic Medical gets second investment from Abell Foundation

The Abell Foundation made its second investment in a year in Vasoptic Medical. Just like last summer, the nonprofit invested $250,000 in the medical device startup. “Expanding our investment in Vasoptic Medical Inc. is a win-win for Baltimore,” said a joint statement released by the Abell Foundation board. “Vasoptic is growing Baltimore’s innovative tech industry and is poised to improve access to affordable healthcare for low-income populations.” For full story click... read more

Join our Effort

As an energetic and devoted team of engineers, scientists, clinicians, technologists, and—most importantly—patients, we at Team Vasoptic are passionate about using innovative technologies to increase access to high-quality care at reduced costs. We are eager to grow the Team through strategic partnerships, research collaborations, and other relationships that embrace a vision of better healthcare through technological innovation. If you would like to be a part of our effort or just want to learn more about what we’re doing, please contact us!

Current Openings

Vasoptic Medical is looking for bright, motivated individuals to join our team. We are committed to producing quality work to support our mission of advancing healthcare through innovative diagnostics. If you think you have what it takes to be part of the Vasoptic team, we look forward to hearing from you!

Vasoptic Medical, Inc.
1215 East Fort Avenue
Suite 203
Baltimore, MD 21230
United States of America
Phone +1 (443) 961-3591

  • This field is for validation purposes and should be left unchanged.

Support